U.S. Senate Minority Leader Mitch McConnell (R-KY), Speaker of the House Kevin McCarthy (R-CA), President Joe Biden, and Senate Majority Leader Chuck Schumer (D-NY) meet in the Oval Office of the White House on May 09, 2023 in Washington, DC. The Congressional lawmakers met with the President to negotiate how to address the debt ceiling before June 1, when U.S. Treasury Secretary Janet Yellen warned Congress that the United States would default on their debts. NO AGREEMENT YET - Elusive debt ceiling talks yield no agreement, WH, GOP eye specific cuts including to IRS. Continue reading … DOUBLE STANDARD - Media joins Dem pile-on against Feinstein -- after'concealing' Fetterman's health condition in 2022. READY FOR INSPECTION - AI-powered system can inspect a car in seconds using bomb-detecting tech.

An updated roadmap to focus federal investments in AI research and development (R&D). The National AI R&D Strategic Plan has been updated (for the first time since 2019), and outlines priorities and goals for federal investments in AI R&D. The executive summary of the document notes that: "The federal government must place people and communities at the center by investing in responsible R&D that serves the public good, protects people's rights and safety, and advances democratic values. This update to the National AI R&D Strategic Plan is a roadmap for driving progress toward that goal." The plan reaffirms the eight strategies from the 2019 plan, and adds a ninth.

Microsoft has called for the US federal government to create a new agency specifically focused on regulating AI, Bloomberg reports. In a Washington, DC-based speech attended by some members of Congress and non-governmental organizations, Microsoft vice chair and president Brad Smith remarked that "the rule of law and a commitment to democracy has kept technology in its proper place" and should do so again with AI. Another part of Microsoft's "blueprint" for regulating AI involves mandating redundant AI circuit breakers, a fail-safe that would allow algorithms to be shut down quickly. Smith also strongly suggested that President Biden create and sign an executive order necessitating that the National Institute of Standards and Technology's (NIST) risk management framework be followed by any federal agencies engaging with AI tools. He added that Microsoft would also adhere to the NIST's guidelines and publish a yearly AI report for transparency.

Neuralink Corp., Elon Musk's brain-implant company, said it received approval from the US Food and Drug Administration to conduct human clinical trials. "This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people," the company said Thursday in a tweet. The FDA and Neuralink did not immediately respond to requests for comment. Musk's startup is developing a small device that will link the brain to a computer, consisting of electrode-laced wires. Placing the device requires drilling into the skull. The approval "is really a big deal," said Cristin Welle, a former FDA official and an associate professor of neurosurgery and physiology at the University of Colorado.

United States regulators have given approval for Elon Musk's start-up Neuralink to test its brain implants on people. Neuralink said on Thursday that it received clearance from the US Food and Drug Administration (FDA) for the first human clinical study of implants which are intended to let the brain interface directly with computers. "We are excited to share that we have received the FDA's approval to launch our first-in-human clinical study," Neuralink said in a post on Twitter – which is owned by Musk. Neuralink prototypes, which are the size of a coin, have so far been implanted in the skulls of monkeys, demonstrations by the startup showed. With the help of a surgical robot, a piece of the skull is replaced with a Neuralink disk, and its wispy wires are strategically inserted into the brain, an early demonstration showed.

The White House has met with AI executives, released an AI bill of rights and an AI risk management framework, but who should run the show? WASHINGTON, D.C. – Congressional lawmakers agreed that AI needs federal oversight, but several were skeptical that President Biden or Vice President Kamala Harris were capable of leading the effort. "I wouldn't trust Joe Biden and Kamala Harris to be able to successfully operate an iPhone, much less be a key focal point of AI policy," Florida Rep. Matt Gaetz told Fox News. "That said, there are some leading minds in the Democratic Party here on the Hill who I think are evaluating these issues with great thoughtfulness: Ted Lieu, Ro Khanna." Rep. Matt Gaetz said neither Biden nor Harris should run the White House's AI efforts.

GOP Rep. Nancy Mace spoke exclusively with Fox News Digital about her thoughts on the rapidly advancing AI sector as Congress races to get ahead of the burgeoning technology. EXCLUSIVE: Rep. Nancy Mace, R-S.C., is calling on the federal government to use artificial intelligence technology to better secure the southwestern border. During an interview with Fox News Digital, Mace suggested the rapidly advancing technology could be used to enhance border patrol agents' monitoring capabilities as border officials continue to see a record number of illegal aliens attempting to cross into the U.S. through Mexico. On one front, she said, AI could help better collect "biometrics of everyone that comes across the border, especially when we're talking about by land and illegally. Rep. Nancy Mace spoke with Fox News Digital about how AI technology can be used to improve border security. "And if you're using AI to find their biometrics in a database or multiple databases, I believe it can be done in a much swifter fashion," the congresswoman explained. "I think that that kind of technology could be used when you're driving through the border.

Texas residents share how familiar they are with artificial intelligence on a scale from one to 10 and detailed how much they use it each day. The "Godfather of A.I.," Geoffrey Hinton, quit Google out of fear that his former employer intends to deploy artificial intelligence in ways that will harm human beings. "It is hard to see how you can prevent the bad actors from using it for bad things," Hinton recently told The New York Times. But stomping out the door does nothing to atone for his own actions, and it certainly does nothing to protect conservatives – who are the primary target of A.I. programmers – from being canceled. Here are five things to know as the battle over A.I. turns hot: Elon Musk recently revealed that Google co-founder Larry Page and other Silicon Valley leaders want AI to establish a "digital god" that "would understand everything in the world.

On the evening of Turkey's most significant elections of the past two decades, Can Semercioğlu went to bed early. For the past seven years, Semercioğlu has worked for Teyit, the largest independent fact-checking group in Turkey, but that Sunday, May 14, was surprisingly one of the quietest nights he remembers at the organization. Before the vote, opinion polls had suggested that incumbent president Recep Tayyip Erdoğan was losing support due to devastating earthquakes in southeastern Turkey that killed nearly 60,000 people and a struggling economy. However, he still managed to secure just under 50 percent of the vote. His main opponent, Kemal Kılıçdaroğlu, who heads the Millet Alliance group of opposition parties, received around 45 percent, meaning the two will face off in a second round scheduled for May 28. "That night we didn't have much work to do because people were talking about the results," Semercioğlu says.

Neuralink, Elon Musk's brain-implant company, said on Thursday it had received a green light from the US Food and Drug Administration (FDA) to kickstart its first in-human clinical study, a critical milestone after earlier struggles to gain approval. Musk has predicted on at least four occasions since 2019 that his medical device company would begin human trials for a brain implant to treat severe conditions such as paralysis and blindness. Yet the company, founded in 2016, only sought FDA approval in early 2022 – and the agency rejected the application, seven current and former employees told Reuters in March. The FDA had pointed out several concerns to Neuralink that needed to be addressed before sanctioning human trials, according to the employees. Major issues involved the lithium battery of the device, the possibility of the implant's wires migrating within the brain and the challenge of safely extracting the device without damaging brain tissue.